Direct screening for Psoriatic Arthritis in psoriasis patients
Accelerating Psoriatic Arthritis Detection in Patients With Psoriasis: Direct-to-patient Administration of Screening Questionnaires (D2P Screening)
This study is testing a new way to find out if people with psoriasis also have Psoriatic Arthritis by giving some patients a screening questionnaire to see if it helps catch more cases early.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 18000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Utah Academic / other |
| Locations | 2 sites (Philadelphia, Pennsylvania and 1 other locations) |
| Trial ID | NCT04110522 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance early detection of Psoriatic Arthritis (PsA) in patients with psoriasis by implementing a direct-to-patient screening approach. It utilizes electronic medical records to identify psoriasis patients who have not been diagnosed with PsA and randomly assigns them to receive a screening questionnaire or not. The study will compare the rates of rheumatologic evaluations and new PsA diagnoses between the two groups, assessing the effectiveness of the screening method. Additionally, it will analyze the characteristics of PsA patients diagnosed through this screening versus those diagnosed through standard care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 or older with a diagnosis of psoriasis but no confirmed diagnosis of Psoriatic Arthritis.
Not a fit: Patients who already have a confirmed diagnosis of Psoriatic Arthritis will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier diagnoses of Psoriatic Arthritis, improving patient outcomes and management.
How similar studies have performed: Other studies have shown promise in using direct-to-patient approaches for screening, suggesting potential success for this method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have an International Classification of Diseases (ICD) code diagnosis of psoriasis but without a confirmed diagnosis of Psoriatic Arthritis prior to study initiation * Be age 18 or older * Be geographically located within a reasonable proximity to the Rheumatology study site Exclusion Criteria: * Have psoriasis and a confirmed diagnosis of psoriatic arthritis made or confirmed by a rheumatologist
Where this trial is running
Philadelphia, Pennsylvania and 1 other locations
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
- University of Utah — Salt Lake City, Utah, United States (Recruiting)
Study contacts
- Principal investigator: Jessica Walsh, M.D. — University of Utah
- Study coordinator: Jessica Walsh, M.D.
- Email: jessica.walsh@hsc.utah.edu
- Phone: 801-581-4333
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.